menu search

IMCR / Wall Street Analysts See a 135% Upside in Immunocore Holdings PLC Sponsored ADR (IMCR): Can the Stock Really Move This High?

Wall Street Analysts See a 135% Upside in Immunocore Holdings PLC Sponsored ADR (IMCR): Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 134.8% in Immunocore Holdings PLC Sponsored ADR (IMCR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. Read More
Posted: Mar 16 2022, 11:17
Author Name: Zacks Investment Research
Views: 111680

IMCR News  

Immunocore to present at upcoming investor conferences

By GlobeNewsWire
October 30, 2023

Immunocore to present at upcoming investor conferences

Immunocore to present at upcoming investor conferences (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md. more_horizontal

Institutions are Buying These 3 Stocks and Analysts Agree

By MarketBeat
September 7, 2023

Institutions are Buying These 3 Stocks and Analysts Agree

A significant but less-spoken or popular metric that investors should keep a watchful eye on is the institutional flow of capital into individual stoc more_horizontal

Immunocore: KIMMTRAK Adoption Continues At Rapid Pace, Expanding To New Markets, Reiterate Buy

By Seeking Alpha
August 27, 2023

Immunocore: KIMMTRAK Adoption Continues At Rapid Pace, Expanding To New Markets, Reiterate Buy

Immunocore's KIMMTRAK segment continues to see rapid adoption, expanding into additional European markets and Israel. The launch curve of KIMMTRAK has more_horizontal

Immunocore to report second quarter 2023 financial results and host call on August 10, 2023

By GlobeNewsWire
August 3, 2023

Immunocore to report second quarter 2023 financial results and host call on August 10, 2023

Immunocore to report second quarter 2023 financial results and host call on August 10, 2023 more_horizontal

Immunocore Holdings: Unlocking The Immune System's Hidden Potential

By Seeking Alpha
June 11, 2023

Immunocore Holdings: Unlocking The Immune System's Hidden Potential

Immunocore Holdings is a leading biotech firm with a promising pipeline of T cell receptor-based bispecific immunotherapies for cancer, autoimmune dis more_horizontal

Immunocore to present at the Bank of America Securities 2023 Health Care Conference

By GlobeNewsWire
May 3, 2023

Immunocore to present at the Bank of America Securities 2023 Health Care Conference

Immunocore to present at the Bank of America Securities 2023 Health C are Conference more_horizontal

Immunocore to present at the 22nd Annual Needham Virtual Healthcare Conference

By GlobeNewsWire
April 11, 2023

Immunocore to present at the 22nd Annual Needham Virtual Healthcare Conference

Immunocore to present at the 22 nd Annual Needham Virtual Healthcare Conference more_horizontal

Immunocore Holdings PLC Sponsored ADR (IMCR) is Attracting Investor Attention: Here is What You Should Know

By Zacks Investment Research
March 30, 2023

Immunocore Holdings PLC Sponsored ADR (IMCR) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching Immunocore Holdings PLC Sponsored ADR (IMCR) quite a bit. Thus, it is worth knowing the facts that could d more_horizontal


Search within

Pages Search Results: